Cargando…
Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives
BACKGROUND: Biofilm formation on indwelling medical devices is a ubiquitous problem causing considerable patient morbidity and mortality. In orthopaedic surgery, this problem is exacerbated by the large number and variety of material types that are implanted. Metallic hardware in conjunction with po...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895847/ https://www.ncbi.nlm.nih.gov/pubmed/20191335 http://dx.doi.org/10.1007/s11999-010-1266-z |
_version_ | 1782183292374614016 |
---|---|
author | Lawson, McKinley C. Hoth, Kevin C. DeForest, Cole A. Bowman, Christopher N. Anseth, Kristi S. |
author_facet | Lawson, McKinley C. Hoth, Kevin C. DeForest, Cole A. Bowman, Christopher N. Anseth, Kristi S. |
author_sort | Lawson, McKinley C. |
collection | PubMed |
description | BACKGROUND: Biofilm formation on indwelling medical devices is a ubiquitous problem causing considerable patient morbidity and mortality. In orthopaedic surgery, this problem is exacerbated by the large number and variety of material types that are implanted. Metallic hardware in conjunction with polymethylmethacrylate (PMMA) bone cement is commonly used. QUESTIONS/PURPOSES: We asked whether polymerizable derivatives of vancomycin might be useful to (1) surface modify Ti-6Al-4V alloy and to surface/bulk modify PMMA bone cement to prevent Staphylococcus epidermidis biofilm formation and (2) whether the process altered the compressive modulus, yield strength, resilience, and/or fracture strength of cement copolymers. METHODS: A Ti-6Al-4V alloy was silanized with methacryloxypropyltrimethoxysilane in preparation for subsequent polymer attachment. Surfaces were then coated with polymers formed from PEG(375)-acrylate or a vancomycin-PEG(3400)-PEG(375)-acrylate copolymer. PMMA was loaded with various species, including vancomycin and several polymerizable vancomycin derivatives. To assess antibiofilm properties of these materials, initial bacterial adherence to coated Ti-6Al-4V was determined by scanning electron microscopy (SEM). Biofilm dry mass was determined on PMMA coupons; the compressive mechanical properties were also determined. RESULTS: SEM showed the vancomycin-PEG(3400)-acrylate-type surface reduced adherent bacteria numbers by approximately fourfold when compared with PEG(375)-acrylate alone. Vancomycin-loading reduced all mechanical properties tested; in contrast, loading a vancomycin-acrylamide derivative restored these deficits but demonstrated no antibiofilm properties. A polymerizable, PEGylated vancomycin derivative reduced biofilm attachment but resulted in inferior cement mechanical properties. CLINICAL RELEVANCE: The approaches presented here may offer new strategies for developing biofilm-resistant orthopaedic materials. Specifically, polymerizable derivatives of traditional antibiotics may allow for direct polymerization into existing materials such as PMMA bone cement while minimizing mechanical property compromise. Questions remain regarding ideal monomer structure(s) that confer biologic and mechanical benefits. |
format | Text |
id | pubmed-2895847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-28958472010-07-29 Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives Lawson, McKinley C. Hoth, Kevin C. DeForest, Cole A. Bowman, Christopher N. Anseth, Kristi S. Clin Orthop Relat Res Symposium: Papers Presented at the 2009 Meeting of the Musculoskeletal Infection Society BACKGROUND: Biofilm formation on indwelling medical devices is a ubiquitous problem causing considerable patient morbidity and mortality. In orthopaedic surgery, this problem is exacerbated by the large number and variety of material types that are implanted. Metallic hardware in conjunction with polymethylmethacrylate (PMMA) bone cement is commonly used. QUESTIONS/PURPOSES: We asked whether polymerizable derivatives of vancomycin might be useful to (1) surface modify Ti-6Al-4V alloy and to surface/bulk modify PMMA bone cement to prevent Staphylococcus epidermidis biofilm formation and (2) whether the process altered the compressive modulus, yield strength, resilience, and/or fracture strength of cement copolymers. METHODS: A Ti-6Al-4V alloy was silanized with methacryloxypropyltrimethoxysilane in preparation for subsequent polymer attachment. Surfaces were then coated with polymers formed from PEG(375)-acrylate or a vancomycin-PEG(3400)-PEG(375)-acrylate copolymer. PMMA was loaded with various species, including vancomycin and several polymerizable vancomycin derivatives. To assess antibiofilm properties of these materials, initial bacterial adherence to coated Ti-6Al-4V was determined by scanning electron microscopy (SEM). Biofilm dry mass was determined on PMMA coupons; the compressive mechanical properties were also determined. RESULTS: SEM showed the vancomycin-PEG(3400)-acrylate-type surface reduced adherent bacteria numbers by approximately fourfold when compared with PEG(375)-acrylate alone. Vancomycin-loading reduced all mechanical properties tested; in contrast, loading a vancomycin-acrylamide derivative restored these deficits but demonstrated no antibiofilm properties. A polymerizable, PEGylated vancomycin derivative reduced biofilm attachment but resulted in inferior cement mechanical properties. CLINICAL RELEVANCE: The approaches presented here may offer new strategies for developing biofilm-resistant orthopaedic materials. Specifically, polymerizable derivatives of traditional antibiotics may allow for direct polymerization into existing materials such as PMMA bone cement while minimizing mechanical property compromise. Questions remain regarding ideal monomer structure(s) that confer biologic and mechanical benefits. Springer-Verlag 2010-02-27 2010-08 /pmc/articles/PMC2895847/ /pubmed/20191335 http://dx.doi.org/10.1007/s11999-010-1266-z Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Symposium: Papers Presented at the 2009 Meeting of the Musculoskeletal Infection Society Lawson, McKinley C. Hoth, Kevin C. DeForest, Cole A. Bowman, Christopher N. Anseth, Kristi S. Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives |
title | Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives |
title_full | Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives |
title_fullStr | Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives |
title_full_unstemmed | Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives |
title_short | Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives |
title_sort | inhibition of staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives |
topic | Symposium: Papers Presented at the 2009 Meeting of the Musculoskeletal Infection Society |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895847/ https://www.ncbi.nlm.nih.gov/pubmed/20191335 http://dx.doi.org/10.1007/s11999-010-1266-z |
work_keys_str_mv | AT lawsonmckinleyc inhibitionofstaphylococcusepidermidisbiofilmsusingpolymerizablevancomycinderivatives AT hothkevinc inhibitionofstaphylococcusepidermidisbiofilmsusingpolymerizablevancomycinderivatives AT deforestcolea inhibitionofstaphylococcusepidermidisbiofilmsusingpolymerizablevancomycinderivatives AT bowmanchristophern inhibitionofstaphylococcusepidermidisbiofilmsusingpolymerizablevancomycinderivatives AT ansethkristis inhibitionofstaphylococcusepidermidisbiofilmsusingpolymerizablevancomycinderivatives |